A staphylococcus aureus infection is a systemic infection caused by the staphylococcus aureus bacteria resulting in skin infection mostly, but develops into major life threatening diseases such as pneumonia, meningitis, endocarditis, osteomyelitis, bacteremia, toxic shock syndrome, and sepsis.
This report contains market size and forecasts of Methicillin-Resistant Staphylococcus Aureus Testing in Global, including the following market information:
Global Methicillin-Resistant Staphylococcus Aureus Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Methicillin-Resistant Staphylococcus Aureus Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Methicillin-Resistant Staphylococcus Aureus Testing include Roche, BD, Bio-Rad, Biomerieux, Abbott, Danaher, Hain Lifescience, Abacus Diagnostica and Eurofins, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Methicillin-Resistant Staphylococcus Aureus Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Methicillin-Resistant Staphylococcus Aureus Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Methicillin-Resistant Staphylococcus Aureus Testing Market Segment Percentages, by Type, 2021 (%)
Blood Testing
Immunodiagnostics
Others
Global Methicillin-Resistant Staphylococcus Aureus Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Methicillin-Resistant Staphylococcus Aureus Testing Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Diagnostic Center
Others
Global Methicillin-Resistant Staphylococcus Aureus Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Methicillin-Resistant Staphylococcus Aureus Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Methicillin-Resistant Staphylococcus Aureus Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Methicillin-Resistant Staphylococcus Aureus Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
BD
Bio-Rad
Biomerieux
Abbott
Danaher
Hain Lifescience
Abacus Diagnostica
Eurofins
Puritan Medical
Arlington Scientific
Luminex